NEW YORK (GenomeWeb News) – Cepheid today said it has received a $3.3-million Small Business Technology Transfer grant from the National Institute of Allergy and Infectious Disease to further develop its Mycobacterium tuberculosis diagnostic.
Cepheid and academic partners at the University of Medicine and Dentistry of New Jersey have worked together to develop a PCR cartridge that can detect M. tuberculosis and predict its resistance to drugs in about one hour.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In a statement, National Institutes of Health Director Francis Collins says sexual harassment is "morally indefensible" and "unacceptable."

Octopuses might owe their intelligence to their liberal alterations to their genes, Cosmos reports.

Stat News and ProPublica report that African Americans are underrepresented in cancer clinical trials.

In Cell this week: genomic analysis of abdominal aortic aneurysm, effect of probiotics on the microbiome, and more.

Sponsored by

This webinar will present a method for RNA-seq expression analysis of FFPE-derived RNA samples that are too degraded for successful application of standard RNA-seq techniques.

Sponsored by

This webinar will detail a comprehensive strategy that a lab has put in place to evaluate  NGS oncology assays for genomic tumor profiling of plasma and tissue samples.